1. Introduction {#sec1-nutrients-09-00235}
===============

Hypertension is widely known to cause cardiovascular diseases including myocardial infarction, congestive heart failure, peripheral vascular disease, stroke, and coronary artery disease \[[@B1-nutrients-09-00235]\], which are strongly related to mortality worldwide \[[@B2-nutrients-09-00235]\]. Hence, the prevention of hypertension is a vital issue for public health. The prevalence of hypertension is 28.9% (31.8% in men, 26.2% in women) in Korean adults, and is higher in elderly groups over 65 years old (60.5% total, 54.3% in men, 65.0% in women) \[[@B3-nutrients-09-00235]\]. The control of blood pressure to prevent hypertension is not a simple undertaking because the mechanism of hypertension is complicated and is related to environmental factors and genetic factors.

There have been several studies that examined the relationship between single nucleotide polymorphism (SNP) and blood pressure or hypertension via genome-wide association studies (GWAS) among Koreans \[[@B4-nutrients-09-00235],[@B5-nutrients-09-00235],[@B6-nutrients-09-00235],[@B7-nutrients-09-00235],[@B8-nutrients-09-00235],[@B9-nutrients-09-00235],[@B10-nutrients-09-00235],[@B11-nutrients-09-00235],[@B12-nutrients-09-00235]\]. However, the mechanism of blood pressure is not sufficiently explained by the genetic effect. Sodium intake and sodium-potassium ratio are generally known to have positive associations with blood pressure and hypertension \[[@B13-nutrients-09-00235],[@B14-nutrients-09-00235],[@B15-nutrients-09-00235],[@B16-nutrients-09-00235],[@B17-nutrients-09-00235],[@B18-nutrients-09-00235],[@B19-nutrients-09-00235],[@B20-nutrients-09-00235]\], while potassium intake is known to have a negative association with blood pressure and hypertension \[[@B13-nutrients-09-00235],[@B21-nutrients-09-00235]\]. The average sodium intake is 3874.1 mg/day in Koreans \[[@B3-nutrients-09-00235]\], which is much higher than the 2000 mg/day recommended by the world health organization (WHO) \[[@B22-nutrients-09-00235]\]. Urinary sodium is considered to reflect actual ingested sodium as a gold standard \[[@B23-nutrients-09-00235]\], but there are difficulties in monitoring it due to extended time and cost in large-scale population studies. The Tanaka equation \[[@B24-nutrients-09-00235]\] and the Kawasaki equation \[[@B25-nutrients-09-00235]\] are generally used to estimate 24 h urinary sodium or urinary potassium \[[@B26-nutrients-09-00235],[@B27-nutrients-09-00235],[@B28-nutrients-09-00235],[@B29-nutrients-09-00235]\] by using spot urinary creatinine, urinary sodium, or urinary potassium.

The protective effect of low sodium diets differs by ethnicity and by individuals according to salt sensitivity \[[@B30-nutrients-09-00235]\]. Therefore, research to examine the interaction effects between sodium intake and genetic effects on the risk of hypertension is needed. There was a previous study of this relationship in Koreans, but the study had a small sample size \[[@B12-nutrients-09-00235]\]. Therefore, the objectives of this study were to investigate the interaction effects of gene variants and 24 h estimated urinary sodium and potassium excretion and sodium-potassium excretion ratios on the risk of hypertension.

2. Methods {#sec2-nutrients-09-00235}
==========

2.1. Study Population {#sec2dot1-nutrients-09-00235}
---------------------

As a part of the Korean genome and epidemiology study (KoGES) cohort, KoGES_Ansan and Ansung study was initially established to investigate the effects of environmental factors on the incidence of chronic diseases among Korean adults in 2001. The KoGES_Ansan and Ansung study primarily included 10,038 participants (5020 in Ansan city and 5018 in Ansung city). [Figure 1](#nutrients-09-00235-f001){ref-type="fig"} shows a flow chart explaining the selection of study participants. Detailed descriptions of the selection process for the study population are below:

**Sample 1**: After excluding participants who had genotyping data of low quality (*n* = 1196) \[[@B31-nutrients-09-00235]\], duplicate data (*n* = 2), missing blood pressure data (*n* = 1), sample 1 included 8839 participants. Sample 1 was analyzed to identify SNPs associated with hypertension.

**Sample 2**: After excluding participants from sample 1 who had no information for spot urinary samples (*n* = 4422) and weight (*n* = 3), sample 2 included 4414 participants. Sample 2 was analyzed to clarify the association between urinary factors and blood pressure or hypertension, and to investigate interaction effects between urinary factors and tagging SNPs on the risk of hypertension.

This study was approved by the electronic institutional review board (e-IRB) of the Korea National Institute for Bioethics Policy (KoNIBP).

2.2. Anthropometric Measurement and Collection of Urinary Samples {#sec2dot2-nutrients-09-00235}
-----------------------------------------------------------------

Information about the participants' socio-demographic status, medical history, diet, and lifestyles was collected through interviewer-administered questionnaires. Height (cm) was measured by using a stadiometer and weight (kg) was measured by using an audiometer. Waist circumference (cm) was measured three times by using a tapeline and the average values were used. Body mass index (BMI, kg/m^2^) was calculated by using weight and height.

Measurement of blood pressure (BP, mmHg) was performed three times with a stethoscope using the Korotkoff method in a supine position. We calculated the average value of systolic BP (SBP) and diastolic BP (DBP). If participants had a systolic BP ≥140 mmHg, a diastolic BP ≥90 mmHg, or took medicine for BP, then we defined them as cases with hypertension (1005 cases and 3412 controls).

Urinary specimens were self-collected by the participants in urine cups, then were transferred to conical tubes and sent to a central laboratory. Spot urine tests for sodium and potassium were quantified through biochemical assays in the central laboratory (Seoul Clinical Laboratories, Seoul, Korea). Twenty-four hour estimated urinary excretion of sodium and potassium were calculated using spot urinary sodium and potassium by using the Tanaka formula \[[@B24-nutrients-09-00235]\] and the Kawasaki formula \[[@B25-nutrients-09-00235]\], which were often used in other studies \[[@B26-nutrients-09-00235],[@B27-nutrients-09-00235],[@B28-nutrients-09-00235],[@B29-nutrients-09-00235]\]. We calculated the 24 h estimated sodium-potassium excretion ratio by using 24 h estimated urinary sodium and potassium excretion.

2.3. Genotyping and Imputation of SNPs {#sec2dot3-nutrients-09-00235}
--------------------------------------

Comprehensive genotyping, quality controls, and imputation of SNPs have been described in a previous study \[[@B31-nutrients-09-00235]\]. Genomic DNA samples were isolated from the blood specimen of participants in the KoGES_Ansan and Ansung study and genotyped using Affymetrix Genome-Wide Human SNP array 5.0 (Affymetrix, Inc., Santa Clara, CA, USA). A total of 500,568 SNPs were genotyped by using Bayesian Robust Linear Modeling Mahalanobis (BRLMM) distance algorithm \[[@B32-nutrients-09-00235]\]. SNPs with missing genotype call rates \>5%, minor allele frequency (MAF) \<0.01, and Hardy-Weinberg equilibrium *p* \< 1 × 10^−6^ were eliminated before association analyses. Quality control was conducted by duplicate genotyping for about 1%--2.5% of samples. Imputation of missing genotypes was accomplished with IMPUTE program \[[@B33-nutrients-09-00235],[@B34-nutrients-09-00235]\] using the Japanese individuals in Tokyo and Chinese individuals in Beijing component of HapMap as the reference \[[@B31-nutrients-09-00235]\].

2.4. Statistical Analysis {#sec2dot4-nutrients-09-00235}
-------------------------

A GWAS was performed with 1,291,657 SNPs that satisfied \<5% Hardy-Weinberg exact test and \<5% minor allele frequency using the PLINK program. To investigate the association between the prevalence of hypertension and each SNP, the logistic multivariable regression model was applied after adjusting for age, sex, BMI, and the recruitment area of participants in the additive genetic model. A total of 178 SNPs were associated with hypertension (*p*-value \< 5 × 10^−5^), and 22 tagging SNPs for 21 gene symbols (24 genes) were selected to analyze the interaction by using the linkage disequilibrium (LD) of SNPs \[[@B35-nutrients-09-00235]\].

Subjects were categorized into tertiles according to the amount of 24 h estimated urinary excretion. The general linear model (GLM) and the Cochran-Mantel-Haenzel analysis were applied to determine potential confounders. Variables with significantly different means or those that showed significant linear trends among the tertile groups were adjusted in the model as covariates. The associations of the 24 h estimated urinary factor with the risk of hypertension were examined. Multivariable logistic regression analysis was applied to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) for the risk of hypertension. The interaction was evaluated by comparing models with and without interaction terms through the likelihood ratio test. All statistical analyses were conducted using SAS version 9.4 (SAS Institute, Inc., Cary, NC, USA), and PLINK \[[@B36-nutrients-09-00235]\].

3. Results {#sec3-nutrients-09-00235}
==========

A total of 178 SNPs were associated with the risk of hypertension. Among them, 22 SNPs were selected as tagging SNPs based on high linkage disequilibrium (LD). [Table 1](#nutrients-09-00235-t001){ref-type="table"} shows the descriptions of the 22 tagging SNPs including chromosome, position, locus, gene symbol, location, minor allele, minor allele frequency, risk allele frequency, OR, test statistic, and *p*-value.

[Table 2](#nutrients-09-00235-t002){ref-type="table"} presents the general characteristics of the participants according to 24 h estimated urinary factors determined with the Tanaka formula. The groups with the highest 24HUNa (24 h urinary Na) and 24HUK (24 h urinary K) were older; had higher BMI and daily energy intake; had more chronic diseases (prevalence of kidney disease, obesity, or diabetes); included more non-smokers and former smokers; and had lower household income compared with the lowest group. Furthermore, the proportion of women was higher in the group with the highest 24HUK. On the other hand, the group with the highest 24HUNa-K ratio (24 h urinary Na-K ratio) was younger, and had lower BMI and daily energy intake, fewer chronic diseases, and included more current smokers and individuals with higher household incomes compared with the lowest group.

The associations of 24 h estimated urinary factors obtained with the Tanaka and Kawasaki formulas with the blood pressure are shown in [Table 3](#nutrients-09-00235-t003){ref-type="table"}. The means of SBP and DBP for the group with the highest 24HUNa were higher than those for the lowest group in all models. The means of SBP and DBP for the group with the highest 24HUK were higher than those for the lowest group in only age-sex adjusted models. The means of SBP and DBP for the group with the highest 24HUNa-K ratio were higher than those for the lowest group in multivariable models.

The associations between 24 h estimated urinary factors determined with the Tanaka and Kawasaki formulas and the risk of hypertension are shown in [Table 4](#nutrients-09-00235-t004){ref-type="table"}. Significant associations between the risk of hypertension and 24HUNa were apparent in the models using the Tanaka formula (third versus first tertile, OR = 1.21; 95% CIs = 1.00--1.48; *p*-trend = 0.037) and the Kawasaki formula (third versus first tertile, OR = 1.27; 95% CIs = 1.04--1.55; *p*-trend = 0.014). There were no significant associations between the risk of hypertension and 24HUK. However, there were significant associations between the risk of hypertension and 24HUNa-K ratio in the age-sex adjusted model and the multivariable model with the estimated Kawasaki formula (third versus first tertile, OR = 1.27; 95% CIs = 1.04--1.56; *p*-trend = 0.022).

[Table 5](#nutrients-09-00235-t005){ref-type="table"} shows statistically significant interactions between gene polymorphisms and 24 h estimated urinary factors using the Tanaka formula. Out of 22 tagging SNPs, two SNPs (c-src tyrosine kinase (CSK) rs1378942, CSK-micro RNA 4513 (MIR4513) rs3784789) had significant interaction effects with 24 h estimated urinary factors on the risk of hypertension. The strongest protective effects of variants of CSK rs1378942 (*p*-interaction = 0.013; OR = 0.08; 95% CIs = 0.01--0.67) and CSK-MIR4513 rs3784789 (*p*-interaction = 0.027; OR = 0.08; 95% CIs = 0.01--0.72) on the risk of hypertension was found in the second tertile for the 24HUNa-K ratio.

[Table 6](#nutrients-09-00235-t006){ref-type="table"} shows the significant interaction between gene polymorphisms and 24 h estimated urinary factors obtained with the Kawasaki formula. Among 22 SNPs, five SNPs (CSK rs1378942, CSK-MIR4513 rs3784789, uncharacterized LOC101929750 (LOC101929750) rs7554672, muskelin 1 (MKLN1) rs1643270, teneurin transmembrane protein 4 (TENM4) rs10466739) showed significant interactions between 24 h estimated urinary factors and the risk of hypertension. LOC101929750 showed the strongest risk effect for hypertension in individuals with a wild type allele who were categorized into the third tertile of 24HUNa (*p*-interaction = 0.028; OR = 2.16; 95% CIs = 1.33--3.50). The strongest protective effect was found in individuals with minor allele homozygotes of LOC101929750 who were categorized into the second tertile of 24HUK (*p*-interaction = 0.034; OR = 0.36; 95% CIs = 0.22--0.58). In the group with minor allele homozygotes of MKLN1 rs1643270, who were categorized into the second tertile of 24HUK, the strongest risk effect was observed (P-interaction = 0.034; OR = 1.55; 95% CIs = 1.01--2.38). As in [Table 5](#nutrients-09-00235-t005){ref-type="table"} (Tanaka formula), the strongest protective effects of variants of CSK rs1378942 (*p*-interaction = 0.012; OR = 0.09; 95% CIs = 0.01--0.83) and CSK-MIR4513 rs3784789 (*p*-interaction = 0.026; OR = 0.10; 95% CIs = 0.01--0.89) were found in the second tertile of the 24HUNa-K ratio. TENM4 rs10466739 showed the strongest risk effect in individuals with heterozygotes of this gene who were in the third tertile of the 24HUNa-K ratio (*p*-interaction = 0.034; OR = 1.43; 95% CIs = 1.07--1.93).

4. Discussion {#sec4-nutrients-09-00235}
=============

This study was conducted in order to identify interaction effects between gene variants and urinary sodium, potassium, and the sodium-potassium ratio on the risk of hypertension, after association analysis of hypertension with urinary factors and genetic factors. The primary finding was related to the protective effects of minor allele homozygotes of CSK rs1378942, CSK-MIR4513 rs3784789 in the middle group (second tertile) of the 24HUNa-K ratio.

There were significant positive associations of blood pressure and hypertension with 24HUNa and 24HUNa-K ratio. These results provide support that low salt diets decrease blood pressure and the risk of hypertension. With regard to 24HUK, there were no significant associations with blood pressure and hypertension. A recent meta-analysis including 14 cohort studies and 27 randomized controlled trials showed that the reduction of salt intake lowers blood pressure \[[@B18-nutrients-09-00235]\]. Other epidemiology studies showed similar results \[[@B14-nutrients-09-00235],[@B15-nutrients-09-00235],[@B16-nutrients-09-00235],[@B17-nutrients-09-00235],[@B19-nutrients-09-00235],[@B20-nutrients-09-00235]\]. A possible mechanism for how sodium and potassium affect blood pressure is as follows. Salt ingestion causes increased sodium and water retention, resulting in extracellular volume expansion, which causes a release of substances that increase heart and blood vessel contraction and affect the renin-angiotensin-aldosterone system \[[@B37-nutrients-09-00235],[@B38-nutrients-09-00235]\]. Potassium increases urinary sodium excretion, which decreases the amount of sodium in the body and leads to vascular smooth muscle relaxation, thereby decreasing peripheral resistance \[[@B39-nutrients-09-00235]\].

A total of 178 SNPs were significantly associated with hypertension in GWAS, and 22 SNPs for 21 gene symbols including ATP2B1 and CSK, which were frequently investigated with blood pressure and hypertension \[[@B12-nutrients-09-00235],[@B40-nutrients-09-00235],[@B41-nutrients-09-00235],[@B42-nutrients-09-00235],[@B43-nutrients-09-00235],[@B44-nutrients-09-00235],[@B45-nutrients-09-00235],[@B46-nutrients-09-00235],[@B47-nutrients-09-00235],[@B48-nutrients-09-00235],[@B49-nutrients-09-00235],[@B50-nutrients-09-00235],[@B51-nutrients-09-00235],[@B52-nutrients-09-00235],[@B53-nutrients-09-00235],[@B54-nutrients-09-00235],[@B55-nutrients-09-00235],[@B56-nutrients-09-00235],[@B57-nutrients-09-00235],[@B58-nutrients-09-00235],[@B59-nutrients-09-00235],[@B60-nutrients-09-00235],[@B61-nutrients-09-00235],[@B62-nutrients-09-00235],[@B63-nutrients-09-00235],[@B64-nutrients-09-00235]\], were selected as tagging SNPs. The mutant allele of ATP2B1 rs11105368 was negatively associated with hypertension, but no significant interaction effects of urinary sodium were found in this study. The results of association between ATP2B1 and hypertension were similar to those from previous studies \[[@B10-nutrients-09-00235],[@B62-nutrients-09-00235],[@B63-nutrients-09-00235]\]. A recent meta-analysis study showed that the group of risk alleles, which were the same as the wild type ATP2B1 rs17249754, was significantly and positively associated with the increase of blood pressure and hypertension (β = 0.15 *p*-value = 1.75 × 10^−11^ with hypertension) \[[@B51-nutrients-09-00235]\]. The mechanism of direct influence between ATP2B1 gene variants and blood pressure has not been clearly identified, but hypotheses are continuously proposed \[[@B65-nutrients-09-00235],[@B66-nutrients-09-00235],[@B67-nutrients-09-00235]\]. ATP2B1 is expressed in vascular endothelium cells, and is related to the regulation of cellular calcium levels, which is known to control the contraction and expansion of vascular smooth cells \[[@B67-nutrients-09-00235]\]. ATP2B1 is related to the extrusion of Ca^2+^ \[[@B66-nutrients-09-00235]\] and the level of ATP2B1 mRNA was higher in hypertensive rats than in non-hypertensive rats \[[@B65-nutrients-09-00235]\].

The prominent finding of this study is the protective effect of minor allele homozygotes of CSK rs1378942 and CSK-MIR4513 rs3784789 on the risk of hypertension in the middle group for the 24HUNa-K ratio. A meta-analysis with two Korean cohorts (The KoGES_Ansan and Ansung Study and The KoGES_health examinees (HEXA) study) found that CSK increases the risk of hypertension in the group with major allele homozygotes of CSK, which is the same as the group with the risk allele \[[@B10-nutrients-09-00235]\]. CSK is known as a protein coding gene, and its molecular function is related to protein binding and protein kinase activity \[[@B68-nutrients-09-00235],[@B69-nutrients-09-00235],[@B70-nutrients-09-00235],[@B71-nutrients-09-00235]\]. Neither the mechanism for the CSK gene variant or for blood pressure has been clearly identified, but there are meaningful studies that assume an association between CSK and blood pressure. c-Src is known to be expressed in vascular smooth muscle cells \[[@B72-nutrients-09-00235]\], to be activated by angiotensin II, and to regulate signaling action, which is associated with the migration, growth, and contraction of human vascular smooth muscle cells \[[@B73-nutrients-09-00235],[@B74-nutrients-09-00235],[@B75-nutrients-09-00235]\]. Although there is no direct mechanism between CSK and blood pressure, blood pressure may be associated with CSK functions related to angiotensin II and vascular smooth muscle cells. Moreover, angiotensin II is known for its role in renal sodium absorption and potassium excretion \[[@B76-nutrients-09-00235]\], which is able to affect blood pressure control. Our results proposed that there are interaction effects of CSK and urinary sodium-potassium ratio on the risk of hypertension. Overall, this study suggested that blood pressure is modified with CSK and urinary sodium-potassium ratio.

CSK-MIR4513 rs3784789 had negative associations with hypertension, and its variant had the strongest protective effects against hypertension in the middle group for the 24HUNa-K ratio. MIR4513 is a kind of micro RNA, which is a non-coding RNA, and it is related to the regulation of the expression of human genes. A recent study found effects of MIR4513 on the long-term averaging of quantitative blood pressure \[[@B77-nutrients-09-00235]\], but there is no information regarding its molecular function or a direct pathway for its relationship with blood pressure and sodium.

MKLN1 rs1643270 and TENM4 rs10466739 were positively associated with hypertension. The group with heterozygotes of MKLN1 rs1643270 had the strongest risk effects on hypertension in the middle group for 24HUK obtained with the Kawasaki formula. MKLN is one of the predicted target genes of micro RNA 27ab-3p, which is associated with smooth muscle cells \[[@B78-nutrients-09-00235]\], thus, it is possible that MKLN is associated with blood pressure control. However, this assumption has not been validated by experimental studies.

The heterozygotes of TENM rs10466739 showed the strongest risk effects on hypertension in the middle group for 24HUNa-K ratio obtained with the Kawasaki formula. TENM4 are protein coding RNA, but there were no studies or other forms of information for them related to blood pressure and sodium.

LOC101929750 rs7554672 was negatively associated with hypertension, and its variant had the strongest protective effects against hypertension in the middle group for 24HUK obtained with the Kawasaki formula. However, LOC101929750 is an uncharacterized RNA gene affiliated with a non-coding RNA, and no details or studies were found on its protein domain structure, molecular function, or pathway with blood pressure.

Since this study used a cross-sectional design, there was a limitation in the ability to investigate the causal association between urinary factors and hypertension. Thus, further studies with independent samples are needed to confirm the interaction effects of gene polymorphisms with urinary sodium, potassium, and sodium-potassium ratio on the risk of hypertension. Among gene variants that showed interaction effects, most genes, including MIR4513, LOC101929750, MKLN1, and TENM4, have not been investigated to determine their molecular functions or pathways in blood pressure control.

There are several advantages to this study. First, to our knowledge, this study is the first large-scale investigation to identify interaction effects of 24 h estimated urinary factors (sodium, potassium, and sodium-potassium ratio) and gene polymorphism associated with the risk of hypertension through GWAS on the risk of hypertension among a Korean population. Second, possible confounding bias was minimized by adjusting various potential confounding factors (age, sex, BMI, energy intake, smoking status, regular exercise status, chronic disease prevalence, recruitment area, and household income) in the multivariable models. Third, though the use of 24 h estimation for urinary sodium using spot urine samples as a predictor of 24 h urinary excretion is still controversial, 24 h estimated urinary formulae were used instead of the spot urine test reflecting sodium intake more precisely; this method is recognized as suitable in population surveys \[[@B79-nutrients-09-00235]\].

5. Conclusions {#sec5-nutrients-09-00235}
==============

In conclusion, the present study results indicate the protective effects of minor allele homozygotes of CSK rs1378942 and CSK-MIR4513 rs3784789 on hypertension in the middle group for the 24HUNa-K ratio. These findings may provide evidence for personalized nutrition to prevent hypertension. Further studies are needed to investigate the mechanisms of MIR4513, MKLN1, TENM4, and LOC101929750 on blood pressure, and to replicate these interaction effects among other populations in Korea.
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nutrients-09-00235-t001_Table 1

###### 

Description of tagging SNPs including interaction analysis in sample 1.

  SNP          CHR   Position    Locus      Gene Symbol    Location           MA   MAF     RAF     OR ^1^   STAT     *p*
  ------------ ----- ----------- ---------- -------------- ------------------ ---- ------- ------- -------- -------- ---------------
  rs10924160   1     243519469   1q44       KIF26B         intron             C    0.345   0.345   1.180    4.146    3.39 × 10^−5^
  rs7554672    1     219339781   1q41       LOC101929750   intron             A    0.411   0.589   0.826    −4.799   1.60 × 10^−6^
  rs7419838    2     38894349    2p22.1     DHX57          intron             A    0.117   0.883   0.766    −4.160   3.19 × 10^−5^
  rs1997377    2     38805170    2P22.1     GALM           intron             T    0.111   0.889   0.750    −4.316   1.59 × 10^−5^
  rs1562855    2     38861972    2p22.1     GEMIN6         intron             C    0.142   0.858   0.781    −4.314   1.60 × 10^−5^
  rs11917719   3     24186676    3p24.2     THRB           intron             T    0.157   0.843   0.796    −4.082   4.47 × 10^−5^
  rs513130     5     72456095    5q13.2     TMEM171        intron             T    0.405   0.595   0.838    −4.334   1.46 × 10^−5^
  rs6457792    6     34872421    6p21.31    UHRF1BP1       intron             G    0.097   0.097   1.305    4.293    1.76 × 10^−5^
  rs10260451   7     142918347   7q35       EPHA1-AS1      intron             A    0.177   0.823   0.799    −4.070   4.70 × 10^−5^
  rs1643270    7     130826034   7q32.3     MKLN1          intron             C    0.479   0.479   1.197    4.569    4.90 × 10^−6^
  rs3800688    7     130843015   7q32.3     PODXL          intron             G    0.419   0.419   1.197    4.600    4.23 × 10^−6^
  rs16927774   8     62771785    8q12.3     ASPH           Intron             C    0.213   0.787   0.820    −4.091   4.30 × 10^−5^
  rs911782     10    123996033   10q26.13   TACC2          intron             T    0.141   0.141   1.242    4.067    4.75 × 10^−5^
  rs10466739   11    78290369    11q14.1    TENM4          intron             C    0.198   0.198   1.221    4.286    1.82 × 10^−5^
  rs11105368   12    88598572    12q21.33   ATP2B1         Intron             C    0.376   0.624   0.810    −5.247   1.55 × 10^−7^
  rs1378942    15    72864420    15q24.1    CSK            Intron             A    0.172   0.828   0.793    −4.380   1.19 × 10^−5^
  rs3784789    15    72869605    15q24.1    CSK, MIR4513   Intron, upstream   G    0.169   0.831   0.799    −4.167   3.08 × 10^−5^
  rs11866964   16    48217182    16q12.1    ZNF423         intron             A    0.231   0.769   0.826    −4.102   4.10 × 10^−5^
  rs1858821    22    30006454    22q12.2    LIMK2          downstream         T    0.145   0.855   0.788    −4.221   2.44 × 10^−5^
  rs4141404    22    30005185    22q12.2    LIMK2          3′ UTR             A    0.145   0.855   0.788    −4.221   2.44 × 10^−5^
  rs2040533    22    30009110    22q12.2    PIK3IP1        missense, 3′ UTR   G    0.146   0.854   0.788    −4.211   2.54 × 10^−5^
  rs2413035    22    29930460    22q12.2    RNF185         intron             T    0.149   0.851   0.791    −4.075   4.61 × 10^−5^

SNP, single nucleotide polymorphism; CHR, chromosome; MA, minor allele; MAF, minor allele frequency; RAF, risk allele frequency; OR, odds ratio; STAT, test statistic; UTR, untranslated region. ^1^ Odds ratios and *p*-values were calculated in multivariable logistic regression models, which were adjusted for age, sex, body mass index (BMI), and recruitment area.

nutrients-09-00235-t002_Table 2

###### 

General characteristics according to 24 h estimated urinary factors obtained with the Tanaka formula in sample 2.

                                       Urinary Factors                                                            
  ------------------------------------ ------------------- ----------------------- ------------------- ---------- ----------
  24HUNa (mEq/day)                     127.8 ± 16.8 ^4^    163.4 ± 8.3             205.8 ± 29.7                   
  Age (years) ^1^                      51.9 ± 0.2 ^a,5^    52.4 ± 0.2 ^a^          53.5 ± 0.2 ^b^      \<0.0001   \<0.0001
  BMI (kg/m^2^) ^2^                    23.8 ± 0.1 ^a^      24.5 ± 0.1 ^b^          25.3 ± 0.1 ^c^      \<0.0001   \<0.0001
  Energy Intake (kcal/day) ^2^         1984.0 ± 21.7 ^a^   2036.3 ± 21.6 ^a,\ b^   2105.1 ± 21.8 ^b^   0.0004     \<0.0001
  Sex, women (%) ^3^                   57.0 ^6^            58.2                    59.0                0.580      0.299
  Cigarette Smoking, current (%) ^2^   28.3                23.4                    21.9                \<0.0001   \<0.0001
  Alcohol Drinking, current (%) ^2^    41.4                44.4                    42.4                0.178      0.588
  Regular Exercise, yes (%) ^2^        51.6                54.6                    57.9                0.003      0.001
  Chronic Disease, yes (%) ^2^         34.7                45.0                    54.2                \<0.0001   \<0.0001
  Family History, yes (%) ^2^          18.3                17.9                    18.7                0.887      0.753
  Area, Ansan (%) ^2^                  52.4                53.7                    48.9                0.026      0.040
  Income, ≥2,000,000 KRW (%) ^2^       31.6                31.2                    25.5                \<0.0001   \<0.0001
  24HUK (mEq/day)                      33.8 ± 3.4          42.6 ± 2.5              55.6 ± 9.1                     
  Age (years)                          50.7 ± 0.2 ^a^      52.4 ± 0.2 ^b^          54.6 ± 0.2 ^c^      \<0.0001   \<0.0001
  BMI (kg/m^2^)                        23.8 ± 0.1 ^a^      24.6 ± 0.1 ^b^          25.2 ±0.1 ^c^       \<0.0001   \<0.0001
  Energy Intake (kcal/day)             1940.6 ± 21.5 ^a^   2031.5 ± 21.7 ^b^       2158.7 ± 22.0 ^c^   \<0.0001   \<0.0001
  Sex, women (%)                       53.1                59.7                    61.6                \<0.0001   \<0.0001
  Cigarette Smoking, current (%)       26.3                22.7                    25.1                0.049      0.396
  Alcohol Drinking, current (%)        43.7                41.8                    42.2                0.594      0.496
  Regular Exercise, yes (%)            48.4                52.3                    64.1                \<0.0001   \<0.0001
  Chronic Disease, yes (%)             35.6                45.6                    53.0                \<0.0001   \<0.0001
  Family History, yes (%)              17.9                17.8                    19.8                0.404      0.226
  Area, Ansan (%)                      70.1                57.5                    25.4                \<0.0001   \<0.0001
  Income, ≥2,000,000 KRW (%)           35.9                30.8                    20.0                \<0.0001   \<0.0001
  24HUNa-K Ratio                       3.0 ± 0.4           3.8 ± 0.2               4.8 ± 0.5                      
  Age (years)                          53.6 ± 0.2 ^c^      52.5 ± 0.2 ^b^          51.7 ± 0.2 ^a^      \<0.0001   \<0.0001
  BMI (kg/m^2^)                        24.5 ± 0.1          24.6 ± 0.1              24.5 ± 0.1          0.781      0.815
  Energy Intake (kcal/day)             2104.7 ± 21.9 ^b^   2030.4 ± 21.8 ^a^       1992.4 ± 21.5 ^a^   0.001      0.0003
  Sex, women (%)                       58.7                60.5                    55.1                0.009      0.045
  Cigarette Smoking, current (%)       27.1                23.2                    23.7                0.007      0.008
  Alcohol Drinking, current (%)        42.0                41.5                    44.5                0.144      0.120
  Regular Exercise, yes (%)            59.8                54.1                    49.6                \<0.0001   \<0.0001
  Chronic Disease, yes (%)             44.1                45.4                    44.4                0.832      0.911
  Family History, yes (%)              19.1                18.3                    17.4                0.499      0.239
  Area, Ansan (%)                      31.1                54.5                    70.0                \<0.0001   \<0.0001
  Income, ≥2,000,000 KRW (%)           23.9                31.0                    33.1                \<0.0001   \<0.0001

T, tertile; 24HUNa, 24 h urinary Na; BMI, body mass index; KRW, Korean Won; 24HUK, 24 h urinary K; 24HUNa-K Ratio, 24 h urinary Na-K ratio. ^1^ Adjusted for sex. ^2^ Adjusted for age and sex. ^3^ Adjusted for age and sex. ^4^ Mean ± standard deviation. ^5^ LS mean ± standard error for continuous variables. Values with different superscript letters within a row are significantly different means by Tukey's multiple comparison test, *p* \< 0.05. ^6^ percentiles for categorical variables.
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###### 

Associations between blood pressure and 24 h estimated urinary factors obtained with Tanaka and Kawasaki formulas in sample 2.

                     Urinary Factors                                                       
  ------------------ --------------------- ------------------ ----------------- ---------- ----------
  Tanaka Formula                                                                           
  24HUNa (mEq/day)   127.8 ± 16.8 ^1^      163.4 ± 8.3        205.8 ± 29.7                 
  SBP (mmHg)                                                                               
  Model 1 ^3^        116.0 ± 0.4 ^a,\ 2^   117.6 ± 0.4 ^b^    121.7 ± 0.4 ^c^   \<0.0001   \<0.0001
  Model 2 ^4^        121.9 ± 1.0 ^a^       122.7 ± 1.0 ^a^    125.8 ± 1.0 ^b^   \<0.0001   \<0.0001
  DBP (mmHg)                                                                               
  Model 1            73.7 ± 0.3 ^a^        75.2 ± 0.3 ^b^     77.0 ± 0.3 ^c^    \<0.0001   \<0.0001
  Model 2            76.6 ± 0.6 ^a^        77.6 ± 0.6 ^a^     78.6 ± 0.7 ^b^    \<0.0001   \<0.0001
  24HUK (mEq/day)    33.8 ± 3.4            42.6 ± 2.5         55.6 ± 9.1                   
  SBP (mmHg)                                                                               
  Model 1            117.0 ± 0.4 ^a^       117.5 ± 0.4 ^a^    120.9 ± 0.4 ^b^   \<0.0001   \<0.0001
  Model 2            123.8 ± 1.0           122.7 ± 1.0        123.5 ± 1.0       0.182      0.718
  DBP (mmHg)                                                                               
  Model 1            74.4 ± 0.3 ^a^        74.8 ± 0.3 ^a^     76.7 ± 0.3 ^b^    \<0.0001   \<0.0001
  Model 2            77.7 ± 0.7            77.1 ± 0.7         77.7 ± 0.7        0.188      0.991
  24HUNa-K ratio     3.0 ± 0.4             3.8 ± 0.2          4.8 ± 0.5                    
  SBP (mmHg)                                                                               
  Model 1            118.1 ± 0.4           118.2 ± 0.4        119.1 ± 0.4       0.188      0.093
  Model 2            121.5 ± 1.0 ^a^       123.1 ± 1.0 ^b^    125.5 ± 1.0 ^c^   \<0.0001   \<0.0001
  DBP (mmHg)                                                                               
  Model 1            75.3 ± 0.3            75.1 ± 0.3         75.5 ± 0.3        0.491      0.487
  Model 2            76.8 ± 0.7 ^a^        77.3 ± 0.6^a^      78.5 ± 0.6 ^b^    0.0002     \<0.0001
  Kawasaki Formula                                                                         
  24HUNa (mEq/day)   158.0 ± 25.2          213.8 ± 13.5       286.4 ± 53.7                 
  SBP (mmHg)                                                                               
  Model 1            116.0 ± 0.4 ^a^       118.0 ± 0.4 ^b^    121.3 ± 0.4 ^c^   \<0.0001   \<0.0001
  Model 2            121.8 ± 1.0 ^a^       123.0 ± 1.0^a^     125.4 ± 1.0 ^b^   \<0.0001   \<0.0001
  DBP (mmHg)                                                                               
  Model 1            73.8 ± 0.3 ^a^        75.2 ± 0.3 ^b^     76.8 ± 0.3 ^c^    \<0.0001   \<0.0001
  Model 2            76.7 ± 0.6 ^a^        77.5 ± 0.6 ^a^     78.5 ± 0.6 ^b^    \<0.0001   \<0.0001
  Kawasaki Formula                                                                         
  24HUK (mEq/day)    41.8 ± 4.6            54.0 ± 3.4         73.3 ± 14.4                  
  SBP (mmHg)                                                                               
  Model 1            116.9 ± 0.4 ^a^       117.8 ± 0.4 ^a^    120.7 ± 0.4 ^b^   \<0.0001   \<0.0001
  Model 2            123.6 ± 1.0           123.0 ± 1.0        123.4 ± 1.0       0.592      0.753
  DBP (mmHg)                                                                               
  Model 1            74.2 ± 0.3 ^a^        75.2 ± 0.3 ^b^     76.4 ± 0.3 ^c^    \<0.0001   \<0.0001
  Model 2            77.5 ± 0.7            77.5 ± 0.7         77.5 ± 0.7        0.998      0.950
  24HUNa-K ratio     2.9 ± 0.5             3.9 ± 0.3          5.2 ± 0.7                    
  SBP (mmHg)                                                                               
  Model 1            117.7 ± 0.4           118.4 ± 0.4        119.2 ± 0.4       0.056      0.017
  Model 2            121.3 ± 1.0 ^a^       123.4 ± 1.0 ^b^    125.4 ± 1.0 ^c^   \<0.0001   \<0.0001
  DBP (mmHg)                                                                               
  Model 1            75.1 ± 0.3            75.3 ± 0.3         75.6 ± 0.3        0.451      0.210
  Model 2            76.6 ± 0.6 ^a^        77.6 ± 0.6 ^a,b^   78.4 ± 0.7 ^b^    0.0001     \<0.0001

T, tertile; 24HUNa, 24 h urinary Na; 24HUK, 24 h urinary K; 24HUNa-K Ratio, 24 h urinary Na-K ratio; SBP, systolic blood pressure; DBP, diastolic BP. ^1^ Mean ± standard deviation. ^2^ LS mean ± standard error. Values with different superscript letters within a row are significantly different means by Tukey's multiple comparison test, *p* \< 0.05. ^3^ Model 1 was adjusted for age and sex. ^4^ Model 2 was adjusted for age, sex, body mass index, energy intake, smoking status, regular exercise status, chronic disease prevalence status, recruitment area, household income, and blood pressure medication.
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###### 

Odds ratios (ORs) and 95% confidence intervals (CIs) for hypertension according to 24 h estimated urinary factors obtained with Tanaka and Kawasaki formulas in sample 2.

                     Urinary Factors                                                
  ------------------ ------------------ ----------------------- ------------------- ----------
  Tanaka Formula                                                                    
  24HUNa (mEq/day)   127.8 ± 16.8 ^1^   163.4 ± 8.3             205.8 ± 29.7        
  Model 1 ^3^        1.00 (ref.)        1.08 (0.89--1.30) ^2^   1.59 (1.33--1.91)   \<0.0001
  Model 2 ^4^        1.00 (ref.)        0.93 (0.76--1.13)       1.21 (1.00--1.48)   0.037
  24HUK (mEq/day)    33.8 ± 3.4         42.6 ± 2.5              55.6 ± 9.1          
  Model 1            1.00 (ref.)        0.96 (0.79--1.15)       1.19 (0.99--1.43)   0.037
  Model 2            1.00 (ref.)        0.79 (0.65--0.97)       0.89 (0.72--1.10)   0.400
  24HUNa-K ratio     3.0 ± 0.4          3.8 ± 0.2               4.8 ± 0.5           
  Model 1            1.00 (ref.)        0.94 (0.79--1.13)       1.14 (0.95--1.36)   0.161
  Model 2            1.00 (ref.)        0.96 (0.79--1.18)       1.22 (0.99--1.49)   0.056
  Kawasaki Formula                                                                  
  24HUNa (mEq/day)   158.0 ± 25.2       213.8 ± 13.5            286.4 ± 53.7        
  Model 1            1.00 (ref.)        1.22 (1.01--1.47)       1.57 (1.31--1.89)   \<0.0001
  Model 2            1.00 (ref.)        1.07 (0.88--1.31)       1.27 (1.04--1.55)   0.014
  24HUK (mEq/day)    41.8 ± 4.6         54.0 ± 3.4              73.3 ± 14.4         
  Model 1            1.00 (ref.)        0.99 (0.82--1.20)       1.14 (0.95--1.37)   0.125
  Model 2            1.00 (ref.)        0.85 (0.70--1.05)       0.88 (0.71--1.09)   0.302
  24HUNa-K ratio     2.9 ± 0.5          3.9 ± 0.3               5.2 ± 0.7           
  Model 1            1.00 (ref.)        1.06 (0.89--1.27)       1.20 (1.00--1.44)   0.046
  Model 2            1.00 (ref.)        1.11 (0.91--1.35)       1.27 (1.04--1.56)   0.022

T, tertile; 24HUNa, 24 h urinary Na; 24HUK, 24 h urinary K; 24HUNa-K Ratio, 24 h urinary Na-K ratio. ^1^ Mean ± standard deviation. ^2^ OR (95% CIs). ^3^ Model 1 was adjusted for age and sex. ^4^ Model 2 was adjusted for age, sex, BMI, energy intake, smoking status, regular exercise status, chronic disease prevalence status, recruitment area, and household income.

nutrients-09-00235-t005_Table 5

###### 

Significant interactions between gene polymorphisms and 24 h estimated urinary factors obtained with Tanaka formula in sample 2.

                            Urinary Factors                                                 
  ------------------------- ------------------- ----------------------- ------------------- -------
  24HUNa-K Ratio                                                                            
  CSK (rs1378942)                                                                           0.013
  AA                        1.00 (ref.)         0.08 (0.01--0.67) ^1^   0.69 (0.20--2.42)   
  AC                        0.61 (0.24--1.56)   0.77 (0.30--1.96)       0.67 (0.26--1.72)   
  CC (wild type)            0.87 (0.35--2.16)   0.80 (0.32--2.00)       1.11 (0.44--2.76)   
  24HUNa-K Ratio                                                                            
  CSK-MIR4513 (rs3784789)                                                                   0.027
  GG                        1.00 (ref.)         0.08 (0.01--0.72)       0.77 (0.22--2.71)   
  CG                        0.61 (0.24--1.54)   0.74 (0.29--1.88)       0.68 (0.27--1.75)   
  CC (wild type)            0.86 (0.35--2.14)   0.80 (0.32--1.99)       1.08 (0.43--2.70)   

T, tertile; 24HUNa-K Ratio, 24 h urinary Na-K ratio. ^1^ Odds ratio (95% Confidence intervals). All models were adjusted for age, sex, body mass index, energy intake, smoking status, regular exercise status, chronic disease prevalence status, recruitment area, and household income.
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###### 

Significant interactions between gene polymorphisms and 24 h estimated urinary factors obtained with Kawasaki formula in sample 2.

                             Urinary Factors                                                 
  -------------------------- ------------------- ----------------------- ------------------- -------
  24HUNa (mEq/day)                                                                           
  LOC101929750 (rs7554672)                                                                   0.028
  AA                         1.00 (ref.)         1.33 (0.77--2.29) ^1^   0.79 (0.44--1.43)   
  AG                         1.33 (0.82--2.14)   1.25 (0.77--2.01)       1.92 (1.20--3.06)   
  GG (wild type)             1.75 (1.07--2.84)   2.04 (1.26--3.31)       2.16 (1.33--3.50)   
  24HUK (mEq/day)                                                                            
  LOC101929750 (rs7554672)                                                                   0.034
  GG (wild type)             1.00 (ref.)         0.92 (0.67--1.27)       0.72 (0.52--1.01)   
  AG                         0.65 (0.48--0.89)   0.58 (0.42--0.79)       0.74 (0.55--1.01)   
  AA                         0.67 (0.44--1.03)   0.36 (0.22--0.58)       0.40 (0.26--0.62)   
  MKLN1 (rs1643270)                                                                          0.034
  CC                         1.00 (ref.)         1.55 (1.01--2.38)       1.22 (0.80--1.87)   
  CT                         1.16 (0.79--1.70)   0.83 (0.56--1.22)       0.85 (0.58--1.26)   
  TT (wild type)             0.97 (0.63--1.48)   0.74 (0.48--1.14)       0.89 (0.58--1.38)   
  24HUNa-K Ratio                                                                             
  CSK (rs1378942)                                                                            0.012
  AA                         1.00 (ref.)         0.09 (0.01--0.83)       0.80 (0.23--2.75)   
  AC                         0.67 (0.27--1.69)   0.94 (0.38--2.35)       0.73 (0.29--1.84)   
  CC (wild type)             0.93 (0.38--2.26)   0.99 (0.41--2.42)       1.25 (0.51--3.05)   
  CSK-MIR4513 (rs3784789)                                                                    0.026
  GG                         1.00 (ref.)         0.10 (0.01--0.89)       0.89 (0.26--3.09)   
  CG                         0.66 (0.26--1.66)   0.91 (0.36--2.28)       0.74 (0.26--1.88)   
  CC (wild type)             0.92 (0.38--2.25)   0.99 (0.40--2.42)       1.22 (0.50--2.99)   
  TENM4 (rs10466739)                                                                         0.034
  TT (wild type)             1.00 (ref.)         0.99 (0.77--1.26)       1.09 (0.85--1.40)   
  CT                         0.86 (0.63--1.16)   1.06 (0.78--1.45)       1.43 (1.07--1.93)   
  CC                         0.31 (0.11--0.93)   1.49 (0.78--2.85)       0.90 (0.43--1.87)   

T, tertile; 24HUNa, 24 h urinary Na; 24HUK, 24 h urinary K; 24HUNa-K Ratio, 24 h urinary Na-K ratio. ^1^ Odds ratio (95% Confidence intervals). All models were adjusted for age, sex, body mass index, energy intake, smoking status, regular exercise status, chronic disease prevalence status, recruitment area, and household income.
